UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
KeyCorp
KEY
$24.8B
| $43.1M | 0.04% |
3,102,841
+4,403
| +0.1% | +$58.6K |
|
452
Constellation Brands
STZ
$22.4B
| $43M | 0.04% |
438,350
-40,245
| -8% | -$3.69M |
|
|
FSL
453
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
| $42.7M | 0.04% |
1,693,345
-512,896
| -23% | -$10.7M |
|
|
XLNX
454
DELISTED
Xilinx Inc
XLNX
| $42.7M | 0.04% |
986,268
+4,929
| +0.5% | +$213K |
|
|
CFN
455
DELISTED
CAREFUSION CORPORATION
CFN
| $42.6M | 0.04% |
718,427
-183,029
| -20% | -$10.5M |
|
456
Campbell Soup
CPB
$6.79B
| $42.3M | 0.04% |
960,289
+6,617
| +0.7% | +$289K |
|
|
SBNY
457
DELISTED
Signature Bank
SBNY
| $41.6M | 0.04% |
330,069
+10,731
| +3% | +$1.28M |
|
458
Quest Diagnostics
DGX
$25.8B
| $41.5M | 0.04% |
618,308
-145,489
| -19% | -$9.18M |
|
459
EQT Corp
EQT
$33B
| $41.4M | 0.04% |
1,003,735
-55,009
| -5% | -$2.6M |
|
460
Annaly Capital Management
NLY
$17.1B
| $41M | 0.04% |
948,556
+83,111
| +10% | +$3.76M |
|
|
DISH
461
DELISTED
DISH Network Corp.
DISH
| $40.7M | 0.04% |
558,837
-6,008
| -1% | -$405K |
|
|
PETM
462
DELISTED
PETSMART INC
PETM
| $40.7M | 0.04% |
500,969
+483
| +0.1% | +$35.8K |
|
463
Teck Resources
TECK
$31.8B
| $40.7M | 0.04% |
2,966,783
+512,297
| +21% | +$7.82M |
|
464
Skyworks Solutions
SWKS
$10.1B
| $40.7M | 0.04% |
559,092
+397,626
| +246% | +$24.7M |
|
465
KLA
KLAC
$255B
| $40.6M | 0.04% |
5,775,960
-138,690
| -2% | -$1.02M |
|
466
Akamai
AKAM
$17.9B
| $40.6M | 0.04% |
644,706
-4,300
| -0.7% | -$259K |
|
467
PVH
PVH
$4.09B
| $40.5M | 0.04% |
315,820
+1,545
| +0.5% | +$185K |
|
|
VRN
468
DELISTED
Veren
VRN
| $40.5M | 0.04% |
1,837,068
-78,633
| -4% | -$2.14M |
|
469
Cheniere Energy
LNG
$53.9B
| $40.4M | 0.04% |
573,272
-11,432
| -2% | -$806K |
|
|
LVLT
470
DELISTED
Level 3 Communications Inc
LVLT
| $40.1M | 0.04% |
812,974
+361,357
| +80% | +$16.7M |
|
|
TFCF
471
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $40.1M | 0.04% |
1,086,126
+134
| +0% | +$4.57K |
|
472
Credicorp
BAP
$31.2B
| $40M | 0.04% |
249,502
-14,300
| -5% | -$2.27M |
|
473
Cenovus Energy
CVE
$53B
| $39.8M | 0.04% |
1,925,045
-414,431
| -18% | -$9.54M |
|
474
Ryanair
RYAAY
$31.2B
| $39.8M | 0.04% |
1,360,703
-191,412
| -12% | -$4.79M |
|
475
Bunge Global
BG
$20.5B
| $39.6M | 0.04% |
436,022
+8,904
| +2% | +$783K |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.